Jun Cao

2.2k total citations
74 papers, 1.6k citations indexed

About

Jun Cao is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jun Cao has authored 74 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Oncology, 29 papers in Molecular Biology and 23 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jun Cao's work include Cancer Treatment and Pharmacology (26 papers), HER2/EGFR in Cancer Research (17 papers) and Advanced Breast Cancer Therapies (10 papers). Jun Cao is often cited by papers focused on Cancer Treatment and Pharmacology (26 papers), HER2/EGFR in Cancer Research (17 papers) and Advanced Breast Cancer Therapies (10 papers). Jun Cao collaborates with scholars based in China, United States and Canada. Jun Cao's co-authors include Biyun Wang, Leiping Wang, Xichun Hu, Zhonghua Tao, Zhonghua Wang, Zhonghua Wang, Jian Zhang, Guizhong Li, Ray Wü and John C. Sanford and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Molecular and Cellular Biology.

In The Last Decade

Jun Cao

70 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jun Cao China 23 810 562 418 336 113 74 1.6k
Valerie Odero-Marah United States 21 967 1.2× 605 1.1× 485 1.2× 327 1.0× 57 0.5× 39 1.5k
Merete Hektoen Norway 14 739 0.9× 592 1.1× 402 1.0× 228 0.7× 178 1.6× 22 1.5k
Zhonghua Xu China 26 1.0k 1.2× 436 0.8× 555 1.3× 419 1.2× 285 2.5× 88 1.9k
Chang Hun Rhee South Korea 22 968 1.2× 287 0.5× 405 1.0× 196 0.6× 194 1.7× 34 1.8k
Wenting Xu China 18 872 1.1× 424 0.8× 412 1.0× 206 0.6× 162 1.4× 46 1.6k
Wendy J. Huss United States 22 981 1.2× 711 1.3× 497 1.2× 664 2.0× 117 1.0× 40 1.8k
Vassiliki Tzelepi Greece 23 733 0.9× 417 0.7× 387 0.9× 676 2.0× 124 1.1× 73 1.7k
Weihua Qiu China 24 738 0.9× 585 1.0× 307 0.7× 366 1.1× 371 3.3× 73 1.7k
Xian Lin China 23 1.2k 1.5× 476 0.8× 637 1.5× 181 0.5× 83 0.7× 63 1.7k

Countries citing papers authored by Jun Cao

Since Specialization
Citations

This map shows the geographic impact of Jun Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Cao more than expected).

Fields of papers citing papers by Jun Cao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Cao. The network helps show where Jun Cao may publish in the future.

Co-authorship network of co-authors of Jun Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Jun Cao. A scholar is included among the top collaborators of Jun Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jun Cao. Jun Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Dai, Jie, Tianxiao Xu, Lifeng Li, et al.. (2025). Atezolizumab plus bevacizumab in patients with unresectable or metastatic mucosal melanoma: 3‐year survival update and multi‐omics analysis. Clinical and Translational Medicine. 15(1). e70169–e70169. 1 indexed citations
3.
Li, Junying, Xiao Yuan, Fengrui Yang, et al.. (2023). PML–LRIF1 interactions form a novel link between promyelocytic leukemia bodies and centromeres. Journal of Molecular Cell Biology. 15(6). 2 indexed citations
4.
Jin, Juan, Bin Li, Ting Li, et al.. (2023). Analysis of clinical features, genomic landscapes and survival outcomes in HER2-low breast cancer. Journal of Translational Medicine. 21(1). 360–360. 18 indexed citations
5.
Jin, Juan, Bin Li, Ting Li, et al.. (2023). Landscape of DNA damage response gene alterations in breast cancer: A comprehensive investigation. Cancer. 129(6). 845–859. 3 indexed citations
6.
Yang, Zhi-hua, Jun Cao, Yucen Song, et al.. (2022). Whole‐exome sequencing identified novel variants in three Chinese Leigh syndrome pedigrees. American Journal of Medical Genetics Part A. 188(4). 1214–1225. 4 indexed citations
7.
8.
Cao, Jun, Mengdi Zhang, Bin Wang, et al.. (2021). Chemoresistance and Metastasis in Breast Cancer Molecular Mechanisms and Novel Clinical Strategies. Frontiers in Oncology. 11. 658552–658552. 55 indexed citations
9.
Zhang, Xiaowei, Feng Jin, Shiyu Jiang, et al.. (2021). Rh-endostatin combined with chemotherapy in patients with advanced or recurrent mucosal melanoma: retrospective analysis of real-world data. Investigational New Drugs. 40(2). 453–460. 7 indexed citations
10.
Meng, Yanchun, Juan Jin, Chengcheng Gong, et al.. (2021). Phase II study of chidamide in combination with cisplatin in patients with metastatic triple-negative breast cancer. Annals of Palliative Medicine. 10(11). 11255–11264. 18 indexed citations
11.
Lin, Ying, Mingxi Lin, Jian Zhang, et al.. (2020). Real-World Data of Pyrotinib-Based Therapy in Metastatic HER2-Positive Breast Cancer: Promising Efficacy in Lapatinib-Treated Patients and in Brain Metastasis. Cancer Research and Treatment. 52(4). 1059–1066. 34 indexed citations
12.
Jiang, Yideng, Shengchao Ma, Huiping Zhang, et al.. (2016). FABP4-mediated homocysteine-induced cholesterol accumulation in THP-1 monocyte-derived macrophages and the potential epigenetic mechanism. Molecular Medicine Reports. 14(1). 969–976. 12 indexed citations
13.
Liu, Rujiao, Jun Cao, Xiang Gao, et al.. (2016). Overall survival of cancer patients with serum lactate dehydrogenase greater than 1000 IU/L. Tumor Biology. 37(10). 14083–14088. 49 indexed citations
14.
Li, Ting, Biyun Wang, Zhonghua Wang, et al.. (2015). Bevacizumab in Combination with Modified FOLFOX6 in Heavily Pretreated Patients with HER2/Neu-Negative Metastatic Breast Cancer: A Phase II Clinical Trial. PLoS ONE. 10(7). e0133133–e0133133. 6 indexed citations
15.
Cao, Jun, Jian Zhang, Zhonghua Wang, et al.. (2014). Hypothyroidism as a potential biomarker of efficacy of famitinib, a novel VEGFR-2 inhibitor in metastatic breast cancer. Cancer Chemotherapy and Pharmacology. 74(2). 389–398. 17 indexed citations
16.
Pan, Hongming, Wenquan Niu, Lan He, et al.. (2013). Contributory Role of Five Common Polymorphisms of RAGE and APE1 Genes in Lung Cancer among Han Chinese. PLoS ONE. 8(7). e69018–e69018. 34 indexed citations
17.
18.
Jiang, Yideng, Jianzhong Zhang, Jiantuan Xiong, et al.. (2007). Ligands of Peroxisome Proliferator-activated Receptor Inhibit Homocysteine induced DNA Methylation of Inducible Nitric Oxide Synthase Gene. Acta Biochimica et Biophysica Sinica. 39(5). 366–376. 19 indexed citations
19.
Jiang, Yideng, Tao Sun, Jiantuan Xiong, et al.. (2007). Hyperhomocysteinemia-mediated DNA Hypomethylation and its Potential Epigenetic Role in Rats. Acta Biochimica et Biophysica Sinica. 39(9). 657–667. 62 indexed citations
20.
Wang, Yichang, Theodore M. Klein, Michael Fromm, et al.. (1988). Transient expression of foreign genes in rice, wheat and soybean cells following particle bombardment. Plant Molecular Biology. 11(4). 433–439. 126 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Valerie Odero-Marah Breakdown of academic impact, for papers by Merete Hektoen Breakdown of academic impact, for papers by Zhonghua Xu Breakdown of academic impact, for papers by Chang Hun Rhee Breakdown of academic impact, for papers by Wenting Xu Breakdown of academic impact, for papers by Wendy J. Huss Breakdown of academic impact, for papers by Vassiliki Tzelepi Breakdown of academic impact, for papers by Weihua Qiu Breakdown of academic impact, for papers by Xian Lin
Rankless by CCL
2026